Researchers sought to determine whether the CAR-T therapy volamcabtagene durzigedleucel (CTX130) would be effective in patients with T-cell lymphoma.

Dogs, rabbits, cats, and more may soon be regular sights at the Amery Hospital and Clinic. Since August, a new program with ...

Cohort A recruitment was re-initiated in July 2024 using higher doses of TCB008 that contained a cumulative dose of up to a billion Gamma Delta T-Cells. Investigator and patient interest in the ...

AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms GenePHIT is a clinical ...

The Global Implantable Drug Delivery Devices Market was valued at USD 26.7 Bn in 2023. It is expected to reach USD 57.1 Bn by 2033, with a CAGR of 8.1% ...

RenovoRx (NASDAQ: RNXT) , a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath(R), a novel, FDA-cleare ...

CHI Mercy Hospital proudly announces their plans to open its own chemo infusion center, a project made possible by the ...

It's mid-morning and it's time for Dr. Gus, M.D. to make the rounds at Baptist Health Lexington. Gus really isn't a doctor; ...

"Only a patient can really appreciate how much ringing the bell matters. So the day he hung it up, it was the most joyous ...

SOLANA BEACH, CA / ACCESS Newswire / February 12, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to ...

VALLEY CITY, N.D. — CHI Mercy Hospital announced it plans to open a chemo infusion center and will hold a dedication ceremony for the project at noon on Friday, Feb. 21, at the hospital. The hospital ...

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ADCETRIS® (brentuximab vedotin) in combination with ...